本报道最初发表于Endpoints News。请点击这里查看原文
Icon said it is continuing to face project cancellations as customers are decreasing their early research spending. As for Medpace, the company said the worst might be over.
Icon表示,随着客户削减早期研发投入,公司仍在遭遇项目被取消的情况。至于Medpace,该公司称最糟糕的时期可能已经过去。
您已阅读10%(267字),剩余90%(2453字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。